<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="other" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.142449.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Study Protocol</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Comparative evaluation of dose dependent efficacy of vitamin C, in relation to oxidative stress level in subjects&#x00a0; with Oral Submucus Fibrosis</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 1 approved, 1 approved with reservations]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Patel</surname>
                        <given-names>Shraddha</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Funding Acquisition</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-1925-0590</uri>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Patel</surname>
                        <given-names>Aditya</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Lohe</surname>
                        <given-names>Vidya</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Mohod</surname>
                        <given-names>Swapnil</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Urkude</surname>
                        <given-names>Minakshi</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Resources</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-7376-3584</uri>
                    <xref ref-type="aff" rid="a3">3</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Patel</surname>
                        <given-names>Satyawansingh</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Formal Analysis</role>
                    <role content-type="http://credit.niso.org/">Project Administration</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Validation</role>
                    <xref ref-type="aff" rid="a4">4</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Oral Medicine and radiology, DMIHER, Wardha, Maharashtra, 442001, India</aff>
                <aff id="a2">
                    <label>2</label>Conservative Dentistry and endodontics, DMIHER, wardha, maharashtra, 442001, India</aff>
                <aff id="a3">
                    <label>3</label>Agadtantra, DMIHER, Wardha, MAHARASHTRA, 442001, India</aff>
                <aff id="a4">
                    <label>4</label>Pharmacology, DMIHER, wardha, maharshtra, 442001, India</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:shraddhaadityapatel@gmail.com">shraddhaadityapatel@gmail.com</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>10</day>
                <month>11</month>
                <year>2023</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2023</year>
            </pub-date>
            <volume>12</volume>
            <elocation-id>1455</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>1</day>
                    <month>11</month>
                    <year>2023</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2023 Patel S et al.</copyright-statement>
                <copyright-year>2023</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/12-1455/pdf"/>
            <abstract>
                <sec>
                    <title>Background</title>
                    <p>Oral submucus fibrosis (OSMF) has a 0.2-0.5 prevalence rate in India. The malignancy rate of OSMF was found to be 7.6%. The focus of pathogenesis is currently on reactive oxygen species levels which can rise to extremely high levels, exceeding the human body&#x2019;s antioxidant defense system and causing oxidative stress that goes beyond physiological limitations. Since oxidative stress plays such a significant part in carcinogenesis and other degenerative diseases, it is fair to believe that antioxidants will help to reduce or even stop these processes. Vitamin C is known for its antioxidant properties which act as a lipid-soluble free radical scavenger in cell membranes. But in some of studies a paradoxical effect of antioxidant doses was found. Thus, the present study will be conducted to evaluate the dose dependent efficacy of Vitamin C level in relation to oxidative stress level in subjects of OSMF.</p>
                </sec>
                <sec>
                    <title>Methods</title>
                    <p>After informed consent, the patient&#x2019;s examination will be conducted. For each individual, 5ml of the blood sample will be withdrawn under all the aseptic precautions and oxidative stress level will be assessed depending on MDA &amp; SOD level in a central research laboratory. Depending on oxidative stress level patients will be divided into two groups.</p>
                    <p>Group I - Moderate oxidative stress in OSMF SI less than 240 but more than 192</p>
                    <p>Group II - High Oxidative Stress in OSMF SI more than 240</p>
                    <p>Single and double doses of Vitamin C will be given to patients accordingly and the MDA &amp; SOD levels will be calculated on day 30,90 days and on 180
                        <sup>th</sup> day</p>
                </sec>
                <sec>
                    <title>Conclusions</title>
                    <p>Positive results of the study will give direction for choosing the correct dose of the antioxidant Vitamin C for OSMF depending on oxidative stress level.</p>
                </sec>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>oral submucous fibrosis</kwd>
                <kwd>reactive oxygen species</kwd>
                <kwd>oxidative stress</kwd>
                <kwd>vitamin C</kwd>
            </kwd-group>
            <funding-group>
                <award-group id="fund-1">
                    <funding-source>Intramural Funding DMIHER</funding-source>
                </award-group>
                <funding-statement>This study received Intramural Funding from DMIHER.</funding-statement>
                <funding-statement>
                    <italic>The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</italic>
                </funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <sec id="sec4" sec-type="intro">
            <title>Introduction</title>
            <p>Oral submucous fibrosis (OSMF) is a common oral precancerous lesion in Asian countries, particularly in regions where betel nuts are chewed. OSMF is caused by abnormal collagen deposition in connective tissues and has an impact on mouth functions. OSMF impairs a patient&#x2019;s quality of life due to discomforting symptoms such as ulceration, xerostomia, a burning sensation, and mouth-opening opening limitation.
                <sup>
                    <xref ref-type="bibr" rid="ref1">1</xref>
                </sup>
            </p>
            <p>The pathogenesis is still believed to be multifactorial in origin. The focus of pathogenesis is currently on reactive oxygen species. During normal metabolism, reactive oxygen and nitrogen species (ROS and RNS) are produced. ROS causes an increase in the production of enzymes such as Super Oxide Dismutase (SOD), which neutralizes reactive oxygen species at low and moderate quantities.
                <sup>
                    <xref ref-type="bibr" rid="ref2">2</xref>
                </sup> So, in everyday life, oxidation and reduction processes are linked with each other. However, in stressful situations, ROS levels can rise to extremely high levels, exceeding the human body&#x2019;s antioxidant defense system and causing oxidative stress that goes beyond physiological limitations. At this point, ROS begins to harm cells in biological systems, resulting in a vicious cycle.
                <sup>
                    <xref ref-type="bibr" rid="ref3">3</xref>
                </sup> In addition, this may also encourage unmanageable lipid peroxidation, which may cause cell injuries through DNA damage and directly inhibit proteins.
                <sup>
                    <xref ref-type="bibr" rid="ref4">4</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref5">5</xref>
                </sup>
            </p>
            <p>Since oxidative stress plays such a significant part in carcinogenesis and other degenerative diseases, it is fair to believe that antioxidants will help to reduce or even stop these processes. In some situations, by preventing free radical generation, detecting free radicals, aiding repair, and creating a favorable environment. Vitamin C is known for its antioxidant properties which act as a free radical scavenger in cell membranes.
                <sup>
                    <xref ref-type="bibr" rid="ref6">6</xref>
                </sup>
                <sup>,</sup>
                <sup>
                    <xref ref-type="bibr" rid="ref7">7</xref>
                </sup> It also prevents the carcinogenic toxin nitrosamine from developing from nitrites in specific meals, as well as improves immune system activity.
                <sup>
                    <xref ref-type="bibr" rid="ref8">8</xref>
                </sup>
            </p>
            <sec id="sec5">
                <title>Rationale</title>
                <p>In 2014 Potter 
                    <italic toggle="yes">et al.</italic>, published their review article in which they presented the major problems with chemoprevention remarking that some substances like beta carotin fail to provide evidence of benefit and one trial suggested excess of large colorectal polyp.
                    <sup>
                        <xref ref-type="bibr" rid="ref5">5</xref>
                    </sup> The author further remarked that supplemental high dose beta carotene not only reduces cancer incidence, it clearly increases risk in high risk groups. The author proposed that ROS might bring out beneficial effect through elimination of cancer cell via apoptosis and an active antioxidant may abrogate the beneficial effect of ROS.</p>
                <p>One of the reason of these controversial observation could be paucity of knowledge regarding optimal doses of antioxidants to be used in relation to the level of oxidative stress.</p>
                <p>
                    <italic toggle="yes">Dose Related Paradoxical Effect</italic>
                </p>
                <p>In 1997 Carney, in 2007 Chemilos G and in 2011 Borkar 
                    <italic toggle="yes">et al.</italic> have studied the efficacy of low and high dose of antioxidant in patients and found that low doses of antioxidants were found to be more efficacious whereas with the higher dose statistically significant reduction in oxidative stress was not observed.
                    <sup>
                        <xref ref-type="bibr" rid="ref8">8</xref>
                    </sup>
                    <sup>&#x2013;</sup>
                    <sup>
                        <xref ref-type="bibr" rid="ref10">10</xref>
                    </sup>
                </p>
                <p>From the literature search, we gathered some observations as follows
                    <list list-type="roman-lower">
                        <list-item>
                            <label>i)</label>
                            <p>Benefits of antioxidants in case of OSMF are still not clear. Observations and conclusions of different studies differ.</p>
                        </list-item>
                        <list-item>
                            <label>ii)</label>
                            <p>For dose dependent actions of antioxidants correlating to oxidative stress levels, literature search through leading search engine the scholar could not find any study regarding efficacy of antioxidant of low and high dose of Vit. C is related to oxidative stress level in subjects of OSMF.</p>
                        </list-item>
                        <list-item>
                            <label>iii)</label>
                            <p>In view of above point it is worthwhile to conduct a clinical study to answer the to Identify knowledge gaps about the importance of a dose related efficacy of antioxidant vitamin C is related to lower and higher oxidative stress levels in subjects of Oral submucous Fibrosis?</p>
                        </list-item>
                    </list>
                </p>
            </sec>
            <sec id="sec6">
                <title>Aim</title>
                <p>To determine oxidative stress level and compare the dose dependent efficacy of Vitamin C in relation to oxidative stress level in subjects with Oral Submucous Fibrosis.</p>
            </sec>
            <sec id="sec7">
                <title>Objective</title>
                <p>
                    <list list-type="order">
                        <list-item>
                            <label>1.</label>
                            <p>To assess the efficacy of low dose Vit. C on mean SOD &amp; MDA level in subject with low oxidative stress.</p>
                        </list-item>
                        <list-item>
                            <label>2.</label>
                            <p>To assess the efficacy of high dose Vit. C on mean SOD &amp; MDA level in subject with low oxidative stress.</p>
                        </list-item>
                        <list-item>
                            <label>3.</label>
                            <p>To assess the efficacy of low dose Vit. C on mean SOD &amp; MDA level in subject with high oxidative stress.</p>
                        </list-item>
                        <list-item>
                            <label>4.</label>
                            <p>To assess the efficacy of high dose Vit. C on mean SOD &amp; MDA level in subject with high oxidative stress.</p>
                        </list-item>
                        <list-item>
                            <label>5.</label>
                            <p>To compare the efficacy of low &amp; high dose Vit. C in low &amp; high oxidative stress level.</p>
                        </list-item>
                        <list-item>
                            <label>6.</label>
                            <p>To correlate the effect of low &amp; high dose Vit. C with low &amp; high oxidative stress level.</p>
                        </list-item>
                    </list>
                </p>
            </sec>
        </sec>
        <sec id="sec8" sec-type="methods">
            <title>Methods</title>
            <sec id="sec9">
                <title>Study design</title>
                <p>The study will be a randomized single blind four arm Interventional Comparative Clinical Study. See 
                    <xref ref-type="fig" rid="f1">Figure 1</xref> for a plan of the study.</p>
                <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                    <label>Figure 1. </label>
                    <caption>
                        <title>Plan of study.</title>
                    </caption>
                    <graphic id="gr1" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/156003/808110f8-77b5-4ada-9b04-b443095fb327_figure1.gif"/>
                </fig>
                <p>The study will be carried out in Sharad Pawar Dental College, Sawangi MegheWardha. All the biochemical procedures will be carried out in Central Research Lab, DMIMS, Sawangi(M) Wardha.</p>
                <p>Patients attending OPD of Oral Medicine &amp; Radiology department of Sharad Pawar Dental College &#x2013;Sawangi Meghe, Wardha will be recruited into the study.</p>
                <p>Random allocation of participants through computer generated random number.</p>
                <p>The study will be conducted in two phases:
                    <list list-type="bullet">
                        <list-item>
                            <label>&#x2022;</label>
                            <p>
                                <bold>Phase 1 Pilot study</bold>
                            </p>
                        </list-item>
                    </list>
                </p>
                <p>A pilot study will be carried out for the purpose of calculating the sample size.
                    <list list-type="bullet">
                        <list-item>
                            <label>&#x2022;</label>
                            <p>
                                <bold>Phase II Conduction of detailed study</bold>
                            </p>
                        </list-item>
                    </list>
                </p>
                <p>Patients attending OPD shall be assessed for eligibility criteria.</p>
            </sec>
            <sec id="sec10">
                <title>IEC clearance</title>
                <p>The Institutional Ethics Committee at Datta Meghe Institute of Higher Education and Research (Deemed to be University), Nagpur, approved the study. Written informed consent will be requested from all patients with OSMF. All patients will be subjected to a thorough history check regarding dietary habits and addiction. They will be clinically examined to determine various stages of oral submucous fibrosis and shall be assessed for eligibility criteria.</p>
            </sec>
            <sec id="sec11">
                <title>Inclusion criteria</title>
                <p>Patients who are above the age of 18 years and are clinically diagnosed with Oral Submucous Fibrosis, diagnosed on the basis of the following clinical parameters. Stomatitis, burning sensation, inter incisal distance, tongue protrusion.</p>
            </sec>
            <sec id="sec12">
                <title>Exclusion criteria</title>
                <p>
                    <list list-type="bullet">
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Subjects with previous radio/chemotherapy or any other treatment modalities for oral submucous fibrosis.</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Subjects with systemic disorders, temporomandibular disorder, or pericoronitis.</p>
                        </list-item>
                        <list-item>
                            <label>&#x2022;</label>
                            <p>Pregnant or lactating mothers.</p>
                        </list-item>
                    </list>
                </p>
            </sec>
            <sec id="sec13">
                <title>Protocol</title>
                <p>The patients will be instructed to discontinue consuming betel nut, tobacco, and pan masala. They will need to quit smoking, and practice good dental hygiene. The study&#x2019;s goal and purpose will be clearly described to each patient, and a formal agreement will be taken. The patient&#x2019;s examination will be conducted by using the diagnostic instrument and natural light. For each individual, 5 ml of the blood sample will be withdrawn under all the aseptic precautions and oxidative stress level will be assessed depending on MDA &amp; SOD level in central research laboratory DMIMS (DU). Method for calculating MDA &amp; SOD The median cubital vein will be used to collect five millilitres of venous blood: For 1 to 2 hours, the blood will be allowed to coagulate at room temperature. To obtain a clear serum sample, the serum will be separated using a centrifuge machine at 3000 rpm for 10 minutes. SOD level will be assessed by Marklund S &amp; Marklund:1974
                    <sup>
                        <xref ref-type="bibr" rid="ref11">11</xref>
                    </sup> method MDA level will be carried out by the Thiobarbituric acid method. From the collected blood sample using spectrophotometer on day 1, day 30 day 90 days, and on 180th day MDA &amp; SOD will be measured.</p>
            </sec>
            <sec id="sec14">
                <title>Statistical analysis</title>
                <p>It will be done by using descriptive &amp; inferential statistics using one way ANOVA, Dunnet D test, Multiple comparison Tukeytest. Software to be used in the analysis will be SPSS latest version.</p>
            </sec>
            <sec id="sec15">
                <title>Implication</title>
                <p>Positive results of study will give direction for choosing best suitable dose of antioxidant Vitamin C for OSMF depending on oxidative stress level.</p>
                <p>
                    <bold>Dissemination:</bold> The study will be published in an indexed journal.</p>
                <p>
                    <bold>Study status</bold>: Study is yet to commence.</p>
            </sec>
            <sec id="sec16">
                <title>Limitation</title>
                <p>The research might be subjected to response bias as we have taken only two doses of antioxidants which could be considered a crucial factor of limitation.</p>
            </sec>
        </sec>
        <sec id="sec17" sec-type="discussion">
            <title>Discussion</title>
            <p>Antioxidants are supposed to maintain the health of cells. This presumption encouraged people worldwide to consume a lot of phytochemical supplements bearing antioxidant properties. In few of articles on antioxidant therapeutics it was observed that antioxidants can work as a double-edged sword if inappropriately used. It has been opined recently that excessive antioxidant therapy can act as a potential immunosuppressant and increase the likelihood of developing malignancies by compromising the natural immune protection system and direct cell and DNA damage. Hence, the best suitable dose of antioxidant must be dependent upon oxidative stress level. Further great care should be taken in selection of antioxidant agents, selection of dosage of antioxidants not to produce harmful effects.</p>
        </sec>
    </body>
    <back>
        <sec id="sec20" sec-type="data-availability">
            <title>Data availability</title>
            <p>No data are associated with this article.</p>
        </sec>
        <ref-list>
            <title>References</title>
            <ref id="ref1">
                <label>1</label>
                <mixed-citation publication-type="book">
                    <collab>World Health Organization</collab>:
                    <source>

                        <italic toggle="yes">IARC Working Group on the Evaluation of carcinogenic risk to humans, International agency for research on cancer, Betel quid &amp; areca nut chewing &amp; some areca nut derived nitrosamines.</italic>
</source>
                    <publisher-name>IARC</publisher-name>;<year>2004</year>.</mixed-citation>
            </ref>
            <ref id="ref2">
                <label>2</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Murti</surname>
                            <given-names>PR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bhonsle</surname>
                            <given-names>RB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pindborg</surname>
                            <given-names>JJ</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Malignant transformation rate in oral submucous fibrosis over a 17-year period.</article-title>
                    <source>

                        <italic toggle="yes">Community Dent. Oral Epidemiol.</italic>
</source>
                    <year>1985 Dec</year>;<volume>13</volume>(<issue>6</issue>):<fpage>340</fpage>&#x2013;<lpage>341</lpage>.
                    <pub-id pub-id-type="doi">10.1111/j.1600-0528.1985.tb00468.x</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref3">
                <label>
3
</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Naik</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Prakash</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Thomas</surname>
                            <given-names>LA</given-names>
                        </name>
</person-group>:
                    <article-title>Role of free radicals and effectiveness of antioxidants in patients with OSMF &amp; OLP- A Systematic Review.</article-title>
                    <source>

                        <italic toggle="yes">Int. J. Life Sci. Pharma. Res.</italic>
</source>
                    <year>JANUARY 2018</year>;<volume>8</volume>(<issue>1</issue>).</mixed-citation>
            </ref>
            <ref id="ref4">
                <label>
4
</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Potter</surname>
                            <given-names>JD</given-names>
                        </name>
</person-group>:
                    <article-title>The failure of cancer chemoprevention.</article-title>
                    <source>

                        <italic toggle="yes">Carcinogenesis.</italic>
</source>
                    <year>2014 May</year>;<volume>35</volume>(<issue>5</issue>):<fpage>974</fpage>&#x2013;<lpage>982</lpage>.
                    <pub-id pub-id-type="pmid">24618374</pub-id>
                    <pub-id pub-id-type="doi">10.1093/carcin/bgu063</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref5">
                <label>5</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Cai</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Scott</surname>
                            <given-names>E</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kholgi</surname>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Cancer Chemoprevention: Evidence of a non linear dose response for the protective effectsof resveratrol in humans &amp; mice.</article-title>
                    <source>

                        <italic toggle="yes">Transl. Med.</italic>
</source>
                    <year>2015 July</year>;<volume>7</volume>(<issue>298</issue>):<fpage>298 ra 117</fpage>.
                    <pub-id pub-id-type="doi">10.1126/scitranslmed.aaa7619</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <label>6</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Carney</surname>
                            <given-names>SL</given-names>
                        </name>
</person-group>:
                    <article-title>Calcitonin&amp; human renal calcium &amp; electrolyte transport.</article-title>
                    <source>

                        <italic toggle="yes">Miner. Electrolyte Metab.</italic>
</source>
                    <year>1997 Jan</year>;<volume>23</volume>(<issue>1</issue>):<fpage>43</fpage>&#x2013;<lpage>47</lpage>.
                    <pub-id pub-id-type="pmid">9058369</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref7">
                <label>7</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Chemilos</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lewis</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Albert</surname>
                            <given-names>N</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Paradoxical effect of Echinocandins across Candida Species in vitro: Evidence for Echinocandins-Specific &amp; Candida species related differences.</article-title>
                    <source>

                        <italic toggle="yes">Antimicrob. Agents Chemother.</italic>
</source>
                    <year>2007 Jun</year>;<volume>51</volume>(<issue>6</issue>):<fpage>2257</fpage>&#x2013;<lpage>2259</lpage>.
                    <pub-id pub-id-type="pmid">17438060</pub-id>
                    <pub-id pub-id-type="doi">10.1128/AAC.00095-07</pub-id>
                    <pub-id pub-id-type="pmcid">PMC1891358</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref8">
                <label>8</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Borkar</surname>
                            <given-names>MA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Patel</surname>
                            <given-names>SS</given-names>
                        </name>
</person-group>:
                    <article-title>Clinical Evaluation of HemidesmusIndicus, Vit. E and Vit. C Co-administration in Patients Suffering from Tuberculosis.</article-title>
                    <source>

                        <italic toggle="yes">JDMIMSU.</italic>
</source>
                    <year>2011</year>;<volume>6</volume>(<issue>3</issue>).</mixed-citation>
            </ref>
            <ref id="ref9">
                <label>9</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kaugars</surname>
                            <given-names>GE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Silverman</surname>
                            <given-names>S</given-names>
                            <suffix>Jr</suffix>
                        </name>

                        <name name-style="western">
                            <surname>Lovas</surname>
                            <given-names>JGL</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A clinical trial of antioxidant supplements in the treatment of oral leukoplakia.</article-title>
                    <source>

                        <italic toggle="yes">Oral Surg. Oral Med. Oral Pathol.</italic>
</source>
                    <year>1994 Oct</year>;<volume>78</volume>(<issue>4</issue>):<fpage>462</fpage>&#x2013;<lpage>468</lpage>.
                    <pub-id pub-id-type="pmid">7800378</pub-id>
                    <pub-id pub-id-type="doi">10.1016/0030-4220(94)90039-6</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref10">
                <label>10</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Cathcart</surname>
                            <given-names>RF</given-names>
                            <suffix>3rd.</suffix>
                        </name>
</person-group>:
                    <article-title>Vitamin C: the nontoxic, nonrate-limited, antioxidant free radical scavenger.</article-title>
                    <source>

                        <italic toggle="yes">Med. Hypotheses.</italic>
</source>
                    <year>1985 Sep</year>;<volume>18</volume>(<issue>1</issue>):<fpage>61</fpage>&#x2013;<lpage>77</lpage>.
                    <pub-id pub-id-type="pmid">4069036</pub-id>
                    <pub-id pub-id-type="doi">10.1016/0306-9877(85)90121-5</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref11">
                <label>11</label>
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Marklund</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Marklund</surname>
                            <given-names>G</given-names>
                        </name>
</person-group>:
                    <article-title>Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase.</article-title>
                    <source>

                        <italic toggle="yes">Eur. J. Biochem.</italic>
</source>
                    <year>1974 Sep 16</year>;<volume>47</volume>(<issue>3</issue>):<fpage>469</fpage>&#x2013;<lpage>474</lpage>.
                    <pub-id pub-id-type="pmid">4215654</pub-id>
                    <pub-id pub-id-type="doi">10.1111/j.1432-1033.1974.tb03714.x</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report401186">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.156003.r401186</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Mahdani</surname>
                        <given-names>Fatma Yasmin</given-names>
                    </name>
                    <xref ref-type="aff" rid="r401186a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0001-6919-418X</uri>
                </contrib>
                <aff id="r401186a1">
                    <label>1</label>Universitas Airlangga, Surabaya, Indonesia</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>28</day>
                <month>8</month>
                <year>2025</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2025 Mahdani FY</copyright-statement>
                <copyright-year>2025</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport401186" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.142449.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p> 
                <bold>Background and Objectives</bold>
            </p>
            <p> The background and objectives are clearly presented; however, the rationale could be strengthened by more explicitly highlighting the research gap and the significance of the study. In the abstract, the statement&#x00a0;
                <italic>&#x201c;Vitamin C is known for its antioxidant properties which act as a lipid-soluble free radical scavenger in cell membranes&#x201d;</italic>&#x00a0;appears questionable. Vitamin C is a water-soluble antioxidant, though it can indirectly protect lipid membranes by regenerating lipid-soluble antioxidants such as Vitamin E. Clarifying this distinction in the background would enhance accuracy and scientific rigor. Furthermore, explicitly explaining the choice to focus on Vitamin C&#x2014;rather than lipid-soluble Vitamin E&#x2014;could serve as a key justification for the study&#x2019;s focus and strengthen the reader&#x2019;s understanding of the study&#x2019;s novelty.</p>
            <p> </p>
            <p> 
                <bold>Study Design</bold>
            </p>
            <p> The chosen design is appropriate for addressing the research question. Nevertheless, it would be beneficial to provide a brief justification for selecting this design over possible alternatives. In addition, please indicate the duration of the study, specifying when recruitment and data collection began for all patients, and include the total study period.</p>
            <p> </p>
            <p> 
                <bold>Methods</bold>
            </p>
            <p> The methodology is generally described; however, the inclusion criteria, data collection procedures, and detailed statistical analysis steps should be elaborated to enable full replication. Furthermore, please clarify whether a grading or staging system for OSMF was applied, and specify which classification was used. Additionally, please provide the rationale for selecting blood-based measurements over alternative matrices such as saliva, as this methodological choice may influence both the interpretation and applicability of the findings.</p>
            <p>Is the study design appropriate for the research question?</p>
            <p>Yes</p>
            <p>Is the rationale for, and objectives of, the study clearly described?</p>
            <p>Yes</p>
            <p>Are sufficient details of the methods provided to allow replication by others?</p>
            <p>Partly</p>
            <p>Are the datasets clearly presented in a useable and accessible format?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>Oral medicine, with a particular focus on salivary gland diseases, oral mucosal pathology, and the role of antioxidants in oral potentially malignant disorders such as Oral Submucous Fibrosis (OSMF).</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
    </sub-article>
    <sub-article article-type="reviewer-report" id="report401182">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.156003.r401182</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Manmuan</surname>
                        <given-names>Suwisit</given-names>
                    </name>
                    <xref ref-type="aff" rid="r401182a1">1</xref>
                    <role>Referee</role>
                </contrib>
                <aff id="r401182a1">
                    <label>1</label>Burapha University, Mueang Chonburi District, Chon Buri, Thailand</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>27</day>
                <month>8</month>
                <year>2025</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2025 Manmuan S</copyright-statement>
                <copyright-year>2025</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport401182" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.142449.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve-with-reservations</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>- The introduction describes in detail the role of reactive oxygen species (ROS) in OSMF pathophysiology, as well as the potential advantages and hazards of antioxidant supplements.</p>
            <p> - The authors accurately identify a gap in the literature about the association between oxidative stress levels and adequate vitamin C intake.The terms low dose and high dose of vitamin C are used, but the specific amounts (mg/day) are not provided. Without identifying the dose, repeatability and clinical translation are limited.</p>
            <p> - The trial does not include a placebo or standard care control group, making it impossible to separate treatment effects from natural illness progression or placebo effects.</p>
            <p> - MDA and SOD levels are clearly measured on Days 1, 30, 90, and 180, but clinical endpoints (e.g., mouth opening, burning sensation) are not reported, despite their importance for patient outcomes.</p>
            <p> -&#x00a0;Adjustments for baseline oxidative stress differences between groups should be considered.</p>
            <p>Is the study design appropriate for the research question?</p>
            <p>Yes</p>
            <p>Is the rationale for, and objectives of, the study clearly described?</p>
            <p>Yes</p>
            <p>Are sufficient details of the methods provided to allow replication by others?</p>
            <p>Partly</p>
            <p>Are the datasets clearly presented in a useable and accessible format?</p>
            <p>Partly</p>
            <p>Reviewer Expertise:</p>
            <p>-</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.</p>
        </body>
    </sub-article>
</article>
